BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38214851)

  • 1. Minimal clinically important difference in the World Health Organization Quality of Life Brief (WHOQOL-BREF) for adults with neurofibromatosis.
    Pietrzykowski MO; Vranceanu AM; Macklin EA; Mace RA
    Qual Life Res; 2024 May; 33(5):1233-1240. PubMed ID: 38214851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
    Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
    JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.
    Wolters PL; Vranceanu AM; Thompson HL; Martin S; Merker VL; Baldwin A; Barnett C; Koetsier KS; Hingtgen CM; Funes CJ; Tonsgard JH; Schorry EK; Allen T; Smith T; Franklin B; Reeve S;
    Neurology; 2021 Aug; 97(7 Suppl 1):S50-S63. PubMed ID: 34230198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfactory results of a psychometric analysis and calculation of minimal clinically important differences of the World Health Organization quality of life-BREF questionnaire in an observational cohort study with lung cancer and mesothelioma patients.
    de Mol M; Visser S; Aerts JGJV; Lodder P; de Vries J; den Oudsten BL
    BMC Cancer; 2018 Nov; 18(1):1173. PubMed ID: 30477456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the World Health Organization WHOQOL-BREF Quality of Life assessment in Singapore.
    Suárez L; Tay B; Abdullah F
    Qual Life Res; 2018 Nov; 27(11):2945-2952. PubMed ID: 30046975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
    Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
    Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
    Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mind-Body Therapy via Videoconferencing in Patients With Neurofibromatosis: Analyses of 1-Year Follow-up.
    Lester EG; Gates MV; Vranceanu AM
    Ann Behav Med; 2021 Feb; 55(1):77-81. PubMed ID: 32421171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial.
    Fishbein NS; Vranceanu AM; Mace RA
    J Neurooncol; 2022 Sep; 159(3):637-646. PubMed ID: 35925531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in south-eastern Australia: normative values for the WHOQOL-BREF in a population-based sample of adults.
    West EC; Williams LJ; Stuart AL; Pasco JA
    BMJ Open; 2023 Dec; 13(12):e073556. PubMed ID: 38072488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric evaluation of an interview-administered version of the WHOQOL-BREF questionnaire for use in a cross-sectional study of a rural district in Bangladesh: an application of Rasch analysis.
    Uddin MN; Islam FMA
    BMC Health Serv Res; 2019 Apr; 19(1):216. PubMed ID: 30953506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the multi-dimensional assessment of quality of life: introducing the WHOQOL-Combi.
    Skevington SM; Rowland C; Panagioti M; Bower P; Krägeloh C
    Qual Life Res; 2021 Mar; 30(3):891-903. PubMed ID: 33331967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.
    Kanaya MR; Greenberg J; Bakhshaie J; Vranceanu AM
    J Neurooncol; 2024 Apr; 167(2):315-322. PubMed ID: 38409461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the Chinese version of the WHOQOL-HIV BREF to assess quality of life among people living with HIV/AIDS: a cross-sectional study.
    Zhu Y; Liu J; Qu B
    BMJ Open; 2017 Aug; 7(8):e016382. PubMed ID: 28827253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.
    Funes CJ; Mace RA; Macklin EA; Plotkin SR; Jordan JT; Vranceanu AM
    J Neurooncol; 2019 Jul; 143(3):505-513. PubMed ID: 31049826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and reliability of the Abbreviated World Health Organization Quality of Life Instrument (WHOQOL-BREF) in the hospitalized trauma population.
    Kruithof N; Haagsma JA; Karabatzakis M; Cnossen MC; de Munter L; van de Ree CLP; de Jongh MAC; Polinder S
    Injury; 2018 Oct; 49(10):1796-1804. PubMed ID: 30154022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the minimal clinically important difference for the PEmbQoL questionnaire, a measure of pulmonary embolism-specific quality of life.
    Akaberi A; Klok FA; Cohn DM; Hirsch A; Granton J; Kahn SR
    J Thromb Haemost; 2018 Dec; 16(12):2454-2461. PubMed ID: 30240543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
    Vranceanu AM; Riklin E; Merker VL; Macklin EA; Park ER; Plotkin SR
    Neurology; 2016 Aug; 87(8):806-14. PubMed ID: 27449066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.
    Mace RA; Doorley J; Bakhshaie J; Cohen JE; Vranceanu AM
    J Neurooncol; 2021 Nov; 155(2):125-132. PubMed ID: 34570301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of depressive symptoms may modify the relationship between the WHOQOL-BREF and its determining factors in community-dwelling older adults.
    Chang YC; Ouyang WC; Lu MC; Wang JD; Hu SC
    Int Psychogeriatr; 2016 Apr; 28(4):591-601. PubMed ID: 26674362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.